Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

Clinical trial NCT04614337 · COMPLETED

Trial details

NCT number: NCT04614337
Sponsor: Lumos Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2020-12-31
Primary completion: 2024-09-04
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.